Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Health Catalyst Inc shares valued at $72,328 were sold by Landry Benjamin on Dec 05 ’25. At $2.64 per share, Landry Benjamin sold 27,425 shares. The insider’s holdings dropped to 100,000 shares worth approximately $0.23 million following the completion of this transaction.
Also, Larson-Green Julie sold 47,997 shares, netting a total of over 128,349 in proceeds. Following the sale of shares at $2.67 each, the insider now holds 73,573 shares.
Before that, BENJAMIN LANDRY had added 27,425 shares to its account. In a trade valued at $73,773, the Officer bought Health Catalyst Inc shares for $2.69 each.
As published in a research note from Piper Sandler on August 27, 2025, Health Catalyst Inc [HCAT] has been rated down from an Overweight to a Neutral and the price target has been revised to $4. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid August. As of August 08, 2025, Cantor Fitzgerald has decreased its “an Overweight” rating to a “Neutral” for HCAT. Earlier on June 17, 2025, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for HCAT stock which previously was a “a Buy”.
Analyzing HCAT Stock Performance
On last trading session, Health Catalyst Inc [NASDAQ: HCAT] rose 1.30% to $2.34. The stock’s lowest price that day was $2.28, but it reached a high of $2.415 in the same session. During the last five days, there has been a drop of approximately -4.49%. Over the course of the year, Health Catalyst Inc shares have dropped approximately -60.34%.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
RSI (Relative Strength Index) is 43.67 on the 14-day chart, showing neutral technical sentiment.
Is Health Catalyst Inc subject to short interest?
Stocks of Health Catalyst Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.98 million shares to 5.05 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 6.03 million shares. A decline of -19.35% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.77 of the overall float, the days-to-cover ratio (short ratio) decline to 7.77.
Which companies own the most shares of Health Catalyst Inc (HCAT)?
In terms of Health Catalyst Inc share price expectations, FactSet research, analysts set an average price target of 4.5 in the next 12 months, up nearly 94.81% from the previous closing price of $2.31. Analysts anticipate Health Catalyst Inc stock to reach 5 by 2026, with the lowest price target being 3. In spite of this, 11 analysts ranked Health Catalyst Inc stock as Buy at the end of 2026.
